Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma
Authors:
- Freda H. PassamFPFreda H. Passam
- Michael G. AlexandrakisMAMichael G. Alexandrakis
- Maria KafousiMKMaria Kafousi
- Marianthi FotinouMFMarianthi Fotinou
- Katerina DarivianakiKDKaterina Darivianaki
- George TsirakisGTGeorge Tsirakis
- Paraskevi A. RoussouPRParaskevi A. Roussou
- Efstathios N. StathopoulosESEfstathios N. Stathopoulos
- Nikolaos M. SiafakasNSNikolaos M. Siafakas
- 1 January 2009
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 205 (1) , 11-20
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphomaPathology - Research and Practice, 2008
- SERUM VEGF AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN HODGKIN LYMPHOMAPediatric Hematology and Oncology, 2007
- Biology of Platelet-Derived Growth Factor and Its Involvement in DiseaseMayo Clinic Proceedings, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- The Androgen Receptor Is Significantly Associated with Vascular Endothelial Growth Factor and Hypoxia Sensing via Hypoxia-Inducible Factors HIF-1a, HIF-2a, and the Prolyl Hydroxylases in Human Prostate CancerClinical Cancer Research, 2005
- Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progressionBreast Cancer Research, 2005
- Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeuticsDrug Resistance Updates, 2005
- Hypoxia-induced Angiogenesis during CarcinogenesisBMB Reports, 2003
- Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin–Reed–Sternberg cells in Hodgkin's diseaseThe Journal of Pathology, 2002
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.Journal of Experimental Medicine, 1990